Treating patients with acute myeloid leukemias (AML) according to the protocol of the AML-01.10 Russian multicenter randomized trial: The coordinating center's results

Terapevticheskii Arkhiv

Volumn 86, Issue 7, 2014, Pages 14-23

  Parovichnikova, E N ^a   Troitskaya, V V ^a   Klyasova, G A ^a   Kuzmina, L A ^a   Sokolov, A N ^a   Paramonova, E V ^a   Galstyan, G M ^a   Kesselman, S A ^a   Drokov, M Yu ^a   Vasilyeva, V A ^a   Obukhova, T N ^a   Kulikov, S M ^a   Savchenko, V G ^a  

^a NATIONAL RESEARCH CENTER FOR HEMATOLOGY   (Russian Federation)

Author keywords

Acute myeloid leukemia; Allogeneic bone marrow transplantation; Multicenter trial; Randomization

Indexed keywords

ANTINEOPLASTIC AGENT; CYTARABINE; DAUNORUBICIN; IDARUBICIN; MITOXANTRONE;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; ARTICLE; BLOOD; CONSOLIDATION CHEMOTHERAPY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE FREE SURVIVAL; DOSE RESPONSE; FEMALE; GENETICS; HUMAN; INDUCTION CHEMOTHERAPY; MAINTENANCE CHEMOTHERAPY; MALE; MORTALITY; MULTICENTER STUDY; RANDOMIZED CONTROLLED TRIAL; RUSSIAN FEDERATION;

ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CONSOLIDATION CHEMOTHERAPY; CYTARABINE; DAUNORUBICIN; DISEASE-FREE SURVIVAL; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; IDARUBICIN; INDUCTION CHEMOTHERAPY; LEUKEMIA, MYELOID, ACUTE; MAINTENANCE CHEMOTHERAPY; MALE; MITOXANTRONE; RUSSIA;

EID: 84908147500     PISSN: 00403660     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (7)

1. Tep apx 2005;7:5-11.
2. Tep apx 2010;7:5-11.
3. Tep apx 2012;7:10-15.
4. Buchner T., Schlenk RF., Schaich M. et al. Acute Myeloid Leukemia (AML): Different Treatment Strategies Versus a Common Standard Arm-Combined Prospective Analysis by the German AML Inteigroup. J Clin Oncol 2012;30(29):3604-3610.
5. Othus M., Kantarjian H., Petersdorf S. et al. Declining rates of treatment-related mortality in patients with newly diagnosed AML given 'intense' induction regimens: a report from SWOG and MD Anderson. Leukemia 2013 Jun. 13. doi:10.1038/leu.2013.176. [Epub ahead of print].
6. Cheson B. D., Bennett J. M., Kopecky K. J. et al. Revised recommendations of the International Working Group for diagnosis, standardization of response criteria, treatment outcomes, and reporting standards for therapeutic trials in acute myeloid leukemia. J Clin Oncol 2003;21(24):4642-4649.
7. Ben De Pauw'a Thomas J., Walsh'a J., Peter Donnelly et al. Revised Definitions of Invasive Fungal Disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Clin Infect Dis 2008;46:1813-1821.